Using an unbiased approach, this important study discovered a role of Ezh2 in the differentiation of granule neuron precursors, the cell of origin for Shh group of medulloblastoma. Furthermore, the ...

After hours: March 21 at 7:19:57 PM EDT Loading Chart for LCTX ...

After hours: March 14 at 7:51:14 PM EDT ...

published in the Feb. 18 edition of the journal Cell, Meekins noted that key infectious-disease experts in the Raymond James network do not believe the report of a new lineage is an item of concern.

It turns out that we also share that genealogy with a prehistoric celebrity ... parents can keep a digital eye on their infant via a baby cam that charts the infant’s respiration on the screen ...

B. Riley analyst Mayank Mamtani lowered the firm’s price target on Lineage Cell Therapeutics (LCTX) to $3 from $4 and keeps a Buy rating on the ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for serious ...

Ratings for Lineage Cell Therapeutics LCTX were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of their ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for serious neurological conditions, today reported its ...